These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1739408)

  • 1. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
    Kierdaszuk B; Bohman C; Ullman B; Eriksson S
    Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
    Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A
    J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
    Carson DA; Haertle T; Wasson DB; Richman DD
    Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.
    Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S
    Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.
    Sarup JC; Fridland A
    Biochemistry; 1987 Jan; 26(2):590-7. PubMed ID: 3030413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
    Haertle T; Carrera CJ; Wasson DB; Sowers LC; Richman DD; Carson DA
    J Biol Chem; 1988 Apr; 263(12):5870-5. PubMed ID: 3258602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
    Johnson MA; Johns DG; Fridland A
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation and salvage of dideoxyadenosine in mammalian cells.
    Plagemann PG; Woffendin C
    Mol Pharmacol; 1989 Jul; 36(1):185-92. PubMed ID: 2787472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase.
    Ullman B
    Adv Exp Med Biol; 1989; 253B():415-20. PubMed ID: 2558543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
    Ullman B; Coons T; Rockwell S; McCartan K
    J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
    Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
    Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
    Bondoc LL; Ahluwalia G; Cooney DA; Hartman NR; Johns DG; Fridland A
    Mol Pharmacol; 1992 Sep; 42(3):525-30. PubMed ID: 1328848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
    Gao WY; Agbaria R; Driscoll JS; Mitsuya H
    J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of human deoxycytidine kinase cDNA.
    Chottiner EG; Shewach DS; Datta NS; Ashcraft E; Gribbin D; Ginsburg D; Fox IH; Mitchell BS
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1531-5. PubMed ID: 1996353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
    Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
    Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
    Balzarini J; Robins MJ; Zou RM; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1987 May; 145(1):277-83. PubMed ID: 3496090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
    Verhoef V; Sarup J; Fridland A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
    Gao WY; Mitsuya H; Driscoll JS; Johns DG
    Biochem Pharmacol; 1995 Jul; 50(2):274-6. PubMed ID: 7632173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
    Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG
    Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.